Emma Walmsley profile: from marketing at L'Oréal to GSK chief

Despite a lukewarm reception from investors, the 47-year-old brings a wealth of experience to Britain’s biggest drugs firm

Emma Walmsley is in line to become one of just six female CEOs in the FTSE 100, having been named as chief executive designate of Britain’s biggest drugs company.

When she takes over GlaxoSmithKline from Sir Andrew Witty on 1 April 2017, Walmsley will be running the biggest of those six companies, with GSK ranking fourth in FTSE 100 with a market value of £80bn.

Related: GSK makes Emma Walmsley most powerful woman in FTSE 100

Continue reading…

Pharmaceutical Stocks


© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us